These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21600957)

  • 1. COMT and age at onset in mood disorders: a replication and extension study.
    Massat I; Kocabas NA; Crisafulli C; Chiesa A; Calati R; Linotte S; Kasper S; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Serretti A; Mendlewicz J
    Neurosci Lett; 2011 Jul; 498(3):218-21. PubMed ID: 21600957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Dallaspezia S; Locatelli C; Radaelli D; Poletti S; Lorenzi C; Pirovano A; Colombo C; Smeraldi E
    J Affect Disord; 2011 Jul; 132(1-2):293-6. PubMed ID: 21397335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.
    Massat I; Souery D; Del-Favero J; Nothen M; Blackwood D; Muir W; Kaneva R; Serretti A; Lorenzi C; Rietschel M; Milanova V; Papadimitriou GN; Dikeos D; Van Broekhoven C; Mendlewicz J
    Mol Psychiatry; 2005 Jun; 10(6):598-605. PubMed ID: 15583702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.
    Soeiro-de-Souza MG; Machado-Vieira R; Soares Bio D; Do Prado CM; Moreno RA
    Bipolar Disord; 2012 Aug; 14(5):554-64. PubMed ID: 22713126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.
    Benedetti F; Dallaspezia S; Colombo C; Lorenzi C; Pirovano A; Smeraldi E
    J Affect Disord; 2010 Sep; 125(1-3):341-4. PubMed ID: 20122740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE; Funke B; Goldberg JF; Bates JA; Jaeger J; Kucherlapati R; Malhotra AK
    Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
    Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
    Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
    Ancín I; Cabranes JA; Vázquez-Álvarez B; Santos JL; Sánchez-Morla E; García-Jiménez MÁ; Fernández C; Barabash A
    World J Biol Psychiatry; 2011 Aug; 12(5):376-84. PubMed ID: 21595525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation.
    Malaguti A; Rossini D; Lucca A; Magri L; Lorenzi C; Pirovano A; Colombo C; Smeraldi E; Zanardi R
    Depress Anxiety; 2011 Jul; 28(7):568-73. PubMed ID: 21449006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
    Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
    Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Barbini B; Bernasconi A; Fulgosi MC; Dallaspezia S; Gavinelli C; Locatelli C; Lorenzi C; Pirovano A; Radaelli D; Smeraldi E; Colombo C
    J Affect Disord; 2010 Feb; 121(1-2):68-72. PubMed ID: 19520435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
    Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
    Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
    Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.